The tertiary life settlement market is where life insurance policies already settled by their original owners are traded between accredited investors and institutional asset managers. It sits one layer above the secondary market (where seniors first sell their policies to licensed providers) and is where the majority of life settlement trading volume actually happens. For individual accredited investors, the tertiary market offers better pricing efficiency, broader inventory diversity, and faster acquisition timelines than waiting for fresh secondary-market originations. Invest in life settlements through HYV's tertiary market access with full pre-acquisition documentation.
When most accredited investors first hear about life settlements, they assume there's only one market — the place where seniors sell their policies. That's actually only the secondary market. Above it sits the tertiary market, where those already-settled policies trade between investors. According to industry research, tertiary trading volume now substantially exceeds secondary volume — and it's where most of the actual accredited-investor acquisitions happen. Yet the tertiary market gets almost no coverage written for individual investors. Most articles speak to institutional asset managers who already understand the plumbing. What follows is the operational reality of the tertiary market translated for the accredited investors who actually deploy capital into it.
What the tertiary market actually is
The life settlement industry operates across three sequential markets. Each one represents a different transaction layer with different participants and different mechanics. Understanding which market you're transacting in changes everything about how you should think about pricing, diligence, and counterparty risk.
The three sequential markets in life insurance trading
The original life insurance issuance. A carrier (Prudential, MetLife, Lincoln, etc.) sells a new policy to an individual or business. No investors involved at this stage.
A senior policyholder (typically 65+) sells their existing in-force policy to a state-licensed life settlement provider for more than the cash surrender value. This is where the asset is born for investors.
Settled policies trade between licensed providers, asset managers, and accredited investors. This is where most direct policy acquisitions actually happen for individual investors.
What gets traded in the tertiary market
The tertiary market handles three distinct types of transactions, as documented by the European Life Settlement Association in its market sizing factsheet:
- Private bilateral deals between market participants — typically a licensed life settlement provider selling individual policies to an asset manager or directly to an accredited investor through a platform. These are the highest-volume, lowest-publicity transactions.
- Active warehousing trades where investors who acquired policies on the secondary market hold them temporarily, then trade them — either individually or in small blocks — to other investors at adjusted pricing reflecting any updated life expectancy or carrier rating data.
- Large portfolio auctions conducted publicly through investment banking intermediaries — typically when a life settlement fund needs liquidity, a closed-end European fund reaches its term, or a defunct platform's portfolio is being wound down.
For individual accredited investors, the first category — private bilateral deals — is where almost all real activity happens. You're not bidding in an auction or warehousing a block of policies. You're acquiring an individual policy that has already passed through secondary-market origination, been documented, and is now being placed with an accredited investor through a platform like HYV.
Why tertiary trumps secondary for individual accredited investors
This is where most accredited investors get the analysis backwards. The intuitive thinking is "I want fresh policies straight from sellers, not used policies traded between investors." That's wrong, and it's wrong for three structural reasons that took me years to fully appreciate when I started in this asset class.
1. Pricing efficiency in the tertiary market
Secondary-market policies are priced through a competitive bidding process between licensed providers, with the seller (the senior policyholder) accepting the highest bid. By the time a policy reaches the tertiary market, all of that price discovery has already happened — and any information advantage a particular buyer thought they had has been competed away. The tertiary market then operates on transparent re-pricing based on time elapsed, updated mortality data, and current investor demand. According to a market analysis by Magna Life Settlements, the tertiary market often trades at a premium to the secondary market because of the deeper pool of institutional capital deployed into it. Counterintuitively, that premium reflects efficiency, not overpricing — it's the pricing that actually clears between sophisticated counterparties.
2. Inventory diversity that doesn't exist in secondary
The secondary market produces only newly settled policies — typically 2,000 to 3,500 transactions per year industry-wide. The tertiary market, by contrast, contains the cumulative inventory of every policy settled over the past 15+ years that hasn't yet matured. That's why portfolio diversification works at the tertiary level in ways it simply can't at the secondary level: you can build a portfolio across LE bands (12 months, 36 months, 60 months, 84 months), across underwriting ages, and across carriers in a way that fresh secondary originations don't permit.
3. Faster acquisition timelines
Tertiary-market acquisitions take 30 to 45 days from selected opportunity to confirmed ownership transfer. Secondary-market origination takes 60 to 90 days because all the underwriting documentation has to be assembled fresh — medical records collection, life expectancy reports, carrier illustrations, seller disclosure compliance, and state-regulated escrow. In tertiary acquisitions, that documentation already exists, so when accredited investors invest in life settlement policies through HYV, they're conducting due diligence on a complete file rather than waiting for it to be assembled.
Tertiary-market trading volume now substantially exceeds secondary-market issuance volume in the U.S. life settlement industry, according to research published by AIR Asset Management. This dynamic confirms that the tertiary layer — not the secondary — is where the real acquisition activity for accredited investors actually happens. SEC Investor Bulletin on Life Settlements describes the structural framework regulators use to oversee both markets.
Browse tertiary life settlement opportunities
HYV sources individually documented policies from licensed providers and presents them to accredited investors with full pre-acquisition documentation — LE reports, carrier ratings, premium schedules, and ownership chain.
Browse ListingsThree operational routes to access tertiary policies
If you've decided the tertiary market is the right place to acquire policies, the next question is structural: how do you actually get in? There are three real routes, each with different capital requirements, control levels, and fee structures. The route that fits depends on capital scale, operational tolerance, and the relationship economics of working through a specialist platform versus doing it yourself.
The matrix above is a starting framework. In my experience working with accredited investors over more than two decades, the second route — advisor-mediated platforms — is the structural sweet spot for the vast majority of individual investors with $250K to $5M to deploy. You get direct ownership of an individually documented policy, the platform handles sourcing and underwriting validation, and the licensed provider executes the regulated transactional steps. There's no fund manager taking 2-and-20, and you can invest in life settlements with full visibility into exactly what you own and why.
The first route — building direct relationships with licensed providers — is technically possible for any accredited investor, but operationally only sensible at family-office scale and above. You're effectively building an internal life settlement desk: relationships with multiple providers, in-house underwriting evaluation, premium servicing infrastructure, and tracking systems for the insureds. Most family offices that go this route eventually still partner with a specialist platform for a meaningful slice of their allocation simply because the operational efficiency is better.
The third route — institutional life settlement funds — has its place but isn't typically how I'd recommend most individual investors enter the asset class. The fund layer adds 2% management plus a performance share, eliminates per-policy visibility, and removes the most attractive feature of life settlement investing: knowing exactly what you own. If you want pooled exposure with less operational involvement, life settlement funds are valid; just understand the fee drag on your effective returns.
Review life settlements available to invest in
HYV operates as the second route — connecting accredited investors with curated tertiary-market policies through licensed provider partners. Direct ownership, full documentation, transparent fees, named advisor relationship.
The tertiary market after GWG: what changed in 2022
You can't write honestly about the tertiary life settlement market without addressing what happened with GWG Holdings. In 2022, GWG declared bankruptcy with approximately $3 billion in life settlement assets after marketing L Bonds aggressively to retail-style investors over the prior decade. The collapse triggered industry-wide changes in how the tertiary market operates — and most of those changes were good for individual accredited investors who arrived after the cleanup.
What the tertiary market looks like post-2022
Three things changed materially in the post-GWG environment, and understanding them changes how you should evaluate any platform offering tertiary access today:
- Diligence standards rose across the industry. Independent life expectancy underwriting (from 21st Services, ISC, Fasano, or Predictive Resources) became the default expectation rather than a premium feature. A-rated carrier requirements became standard. Ownership chain documentation tightened. Platforms that used in-house LE estimates or weaker carriers got priced out of the institutional buy side.
- Disclosure quality became the differentiator. Pre-GWG, many platforms could get away with vague summaries of policy characteristics. Post-GWG, sophisticated investors and the institutional buy side demanded the full document stack — LE report, carrier rating disclosure, premium schedule, ownership chain — before committing capital. Platforms that resisted that disclosure level lost meaningful order flow.
- Regulatory scrutiny intensified. The SEC and state insurance regulators reviewed life settlement marketing practices with significantly more attention. Aggressive retail marketing of life settlement-backed instruments effectively disappeared. The asset class returned to its institutional roots — accessible to accredited investors through advisor-mediated platforms, but no longer marketed as a retail income product.
The tertiary life settlement market is regulated indirectly through the same state-level frameworks that govern the secondary market — primarily the NAIC Viatical Settlements Model Act and the NCOIL Life Settlement Model Act, adopted by 43 U.S. states plus DC. Licensed life settlement providers operate under state insurance department oversight, and tertiary trades involving those providers inherit the underlying regulatory framework. Federal securities law applies through the SEC when life settlement investments qualify as securities, restricting investor eligibility to accredited investors as defined under SEC Rule 501 of Regulation D.
Industry self-regulation is led by the Life Insurance Settlement Association (LISA) and the European Life Settlement Association (ELSA), which publish market data, ethical standards, and best-practice guidance. According to LISA's 2024 market data survey, U.S. licensed providers completed 2,699 secondary-market transactions worth $601 million in face value during 2024 — a fraction of estimated tertiary-market volume that year. Tertiary trading is largely private and bilateral, which means industry-wide volume figures are estimates rather than reported totals, but consensus across multiple market researchers (AIR Asset Management, Conning, ELSA) places tertiary volume at multiples of secondary volume.
For accredited investors evaluating tertiary access, the practical post-GWG checks remain consistent: platform sources execute through state-licensed life settlement providers; independent life expectancy underwriting from a recognized firm; A-rated carrier acceptance criteria; transparent fee disclosure; and direct named-advisor relationship. These are the same standards that institutional investors applied before GWG; they are now table-stakes for the broader market rather than aspirational benchmarks.
Invest in life settlements through institutional-grade tertiary access
HYV's process incorporates the post-2022 diligence standards as defaults: independent LE underwriting, A-rated carrier requirement, full document stack delivered before commitment, named advisor relationship.
Frequently asked questions
What is the difference between secondary and tertiary life settlement markets?
The secondary market is where senior policyholders (typically 65+) first sell their existing life insurance policies to state-licensed life settlement providers for more than the cash surrender value. The tertiary market is the layer above — where those already-settled policies trade between licensed providers, asset managers, and accredited investors. According to industry research from AIR Asset Management and ELSA, tertiary trading volume substantially exceeds secondary-market issuance volume in the U.S. life settlement industry today.
Is the tertiary life settlement market regulated?
The tertiary market is regulated indirectly through the same state-level frameworks that govern the secondary market — primarily the NAIC Viatical Settlements Model Act and the NCOIL Life Settlement Model Act, adopted by 43 U.S. states plus DC. Licensed providers operate under state insurance department oversight, and tertiary trades involving those providers inherit the underlying regulatory framework. Federal securities law also applies when life settlement investments qualify as securities — restricting investor eligibility to accredited investors as defined under SEC Rule 501 of Regulation D.
Why do tertiary-market policies sometimes trade at a premium to secondary-market policies?
Tertiary-market policies trade at premiums for two main reasons. First, deeper institutional capital chasing a finite pool of policies bids prices up. Second, tertiary policies have a documented track record — premium history, any LE updates, carrier behavior — that reduces information asymmetry compared to fresh secondary-market policies. The premium reflects price discovery efficiency rather than overpricing. Counterintuitively, this is healthy for individual accredited investors, who benefit from the same pricing transparency as institutional buyers.
How long does a tertiary-market acquisition take to close?
Tertiary-market acquisitions typically close in 30 to 45 days from selected opportunity to confirmed ownership transfer. Secondary-market origination takes 60 to 90 days because all the underwriting documentation has to be assembled fresh — medical records collection, life expectancy reports, carrier illustrations, seller disclosure compliance, and escrow. In tertiary acquisitions, that documentation already exists, so the investor focuses on diligence review rather than waiting for documents to be created.
Can individual accredited investors really access the tertiary market?
Yes — through advisor-mediated platforms like High Yield Vault that connect accredited investors with licensed life settlement provider partners. Historically the tertiary market was accessible primarily to institutional asset managers and family offices. Over the past decade, specialist platforms emerged to make individual policy ownership available to accredited investors at $250K and above, with full pre-acquisition documentation. Direct provider relationships remain practical mainly for capital allocations of $5M and up.
What changed in the tertiary market after the 2022 GWG Holdings collapse?
Three substantive changes followed GWG's bankruptcy. First, diligence standards rose industry-wide — independent life expectancy underwriting from recognized firms (21st Services, ISC, Fasano, Predictive Resources) became the default rather than a premium feature, and A-rated carrier requirements became standard. Second, disclosure quality became the differentiator — full document stacks delivered pre-commitment became table-stakes. Third, regulatory scrutiny intensified — aggressive retail marketing of life settlement-backed instruments effectively disappeared, and the asset class returned to its institutional roots. The post-GWG environment is structurally better for careful accredited investors than what came before.
Does High Yield Vault operate in the secondary or tertiary market?
High Yield Vault operates as a tertiary-market platform — sourcing already-settled policies from our network of licensed life settlement provider partners and presenting them to accredited investors with full pre-acquisition documentation. We are not a licensed life settlement provider ourselves; the regulated transactional steps execute through our partner network. This structure means investors get curated tertiary access plus full secondary-market regulatory protection — the licensed provider handles state-licensed activities while HYV focuses on opportunity sourcing, advisor relationships, and investor experience.
